KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Retained Earnings (2016 - 2025)

Biogen (BIIB) has 17 years of Retained Earnings data on record, last reported at $20.6 billion in Q4 2025.

  • For Q4 2025, Retained Earnings rose 15190.09% year-over-year to $20.6 billion; the TTM value through Dec 2025 reached $20.6 billion, up 15190.09%, while the annual FY2025 figure was $20.6 billion, 15190.09% up from the prior year.
  • Retained Earnings reached $20.6 billion in Q4 2025 per BIIB's latest filing, up from -$214.8 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $20.6 billion in Q4 2025 and bottomed at -$214.8 million in Q3 2025.
  • Average Retained Earnings over 5 years is $2.9 billion, with a median of -$149.8 million recorded in 2023.
  • Peak YoY movement for Retained Earnings: plummeted 56.52% in 2023, then soared 15190.09% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$106.7 million in 2021, then crashed by 54.55% to -$164.9 million in 2022, then increased by 6.79% to -$153.7 million in 2023, then grew by 11.39% to -$136.2 million in 2024, then skyrocketed by 15190.09% to $20.6 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were $20.6 billion in Q4 2025, -$214.8 million in Q3 2025, and $20.1 billion in Q2 2025.